Skip to main content
Terug
Watch Compare

Verrica Pharmaceuticals Inc.

Datakwaliteit: 100%
VRCA
Nasdaq Manufacturing Chemicals
€ 5,11
▼ € 0,72 (-12,35%)
Marktkapitalisatie: 99,29 M
Prijs
€ 5,78
Marktkapitalisatie
99,29 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Revenue grew 31,22% annually over 5 years — strong growth
Negative free cash flow of -17,63 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 339,00%
Capital efficient — spends only 0,00% of revenue on capex

Groei

Revenue Growth (5Y)
31,22%
Boven sectorgemiddelde (1,82%)
Revenue (1Y)370,22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-88,02%
Net Margin-50,27%
Op. Margin-34,25%

Veiligheid

Debt / Equity
N/A
Current Ratio1,25
Interest Coverage-1,57

Waardering

PE (TTM)
-5,55
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1364 peers)
Metriek Aandeel Sector Mediaan
P/E -5,6 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -50,3 -41,5
Rev Growth 5Y % 31,2 1,8
D/E — 0,3

ETFs Holding This Stock

BRSIX BRSIX
0,02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) 370,22% Revenue Growth (3Y) 163,50%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 31,22% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 35,58 M Net Income (TTM) -17,89 M
ROE N/A ROA -44,71%
Gross Margin N/A Operating Margin -34,25%
Net Margin -50,27% Free Cash Flow (TTM) -17,63 M
ROIC -88,02% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1,25
Interest Coverage -1,57 Asset Turnover 0,89
Working Capital 7,37 M Tangible Book Value -17,04 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5,55 Forward P/E N/A
P/B Ratio N/A P/S Ratio 2,79
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -17,75%
Market Cap 99,29 M Enterprise Value 99,82 M
Per Share
EPS (Diluted TTM) -1,68 Revenue / Share 2,07
FCF / Share -1,03 OCF / Share -1,03
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0,00% FCF Conversion 98,55%
SBC-Adj. FCF N/A Growth Momentum 339,00

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 35,58 M 7,57 M 5,12 M 9,03 M 12,00 M
Net Income -17,89 M -76,58 M -67,00 M -24,49 M -35,08 M
EPS (Diluted) -1,68 -1,48 -1,48 -0,72 —
Gross Profit — — — — —
Operating Income -12,19 M -65,92 M -65,76 M -21,30 M -30,91 M
EBITDA — — — — —
R&D Expenses 8,86 M 11,84 M 20,30 M 12,20 M 15,93 M
SG&A Expenses 35,22 M 58,82 M 47,31 M — —
D&A — — — — —
Interest Expense 7,74 M 9,41 M 3,96 M 2,17 M 4,30 M
Income Tax 0,0 0,0 0,0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 47,13 M 54,13 M 81,60 M 44,72 M 80,13 M
Total Liabilities 22,39 M 63,99 M 61,83 M 4,69 M 47,52 M
Shareholders' Equity 24,74 M -9,86 M 19,76 M 40,03 M 32,61 M
Total Debt 0,0 30,98 M 42,87 M 0,0 41,69 M
Cash & Equivalents 30,15 M 46,33 M 69,55 M 34,27 M 15,75 M
Current Assets 42,54 M 51,18 M 77,53 M 39,12 M 74,33 M
Current Liabilities 16,44 M 29,01 M 17,02 M 3,46 M 46,06 M